S&P 500 Declines as Overinflated AI Stocks Lose Some Air
The S&P 500 (Index: SPX) lost money every day of the trading week ending on Friday, 26 June 2026. By week’s end, the index dropped 1.95% from the previous week’s close, ending up at 7,354.02. That’s about 3.4% below its 2 June 2026 record high.
It wasn’t a big change as stock market volatility goes, but there is something interesting going on within it. The biggest stocks within the S&P 500, many of them making big bets on Artificial Intelligence (AI) technologies or having become big because they produce the infrastructure those bets on AI require, were down.
Since the S&P 500 weights its holdings of its component stocks by their market capitalization, having these biggest stocks of the index decline would be expected to take a bite out of the index as a whole. Which is indeed what happened.
What wouldn’t necessarily be expected in that scenario is for the other, smaller stocks of the index to power higher, which also happened.
In the latest update of the alternative futures chart, we’ve added a new redzone forecast range to compensate for the echo of 2025′s AI-powered recovery from the ‘Liberation Day’ global tariff event, during which we anticipate the S&P 500 will undershoot the dividend futures-based model‘s raw projections.
The echo effect arises because the model incorporates historic stock price data as the base reference points of its projections of the index’ likely future trajectories. We add the redzone forecast ranges when we know the echoes of the past volatility of stock prices will affect the model’s projections, in which we bridge across the period that will be affected. For this newest redzone forecast range, we’ve assumed investors will focus on the now current quarter of 2026-Q3 in setting current day stock prices, anchoring it on that trajectory on 18 June 2026 and setting the other end on the model’s projections of where the S&P 500 will be on 27 July 2026, provided they hold their forward looking focus on 2026-Q3.
We expect investors will mostly hold their focus on this quarter because of the likely timing for when the Federal Reserve will hike short term U.S. interest rates. On that count, the CME Group’s FedWatch Tool continued to project the Fed will hike the Federal Funds rate by a quarter point to a target range of 3.75-4.00% after the Fed meets on 16 September (2026-Q3).
Meanwhile, here are the market moving headlines that investors had to absorb during the trading week that was:
- Monday, 22 June 2026
-
- Signs and portents for the U.S. economy:
- New chief minion’s style affecting how investors read Federal Reserve’s intentions:
- Mixed economic signs developing in China:
- China’s 618 shopping festival sees flat e-commerce sales as shoppers remain cautious
- China youth jobless rate drops to 11-month low in May
- Bigger stimulus slowly developing in Japan:
- ECB minions say their ‘neutral rate’ analysis is useless for policymaking:
- S&P 500, Nasdaq end in the red as tech suffers, traders weigh in Middle East peace talks
- Tuesday, 23 June 2026
-
- Signs and portents for the U.S. economy:
- US Manufacturing Hits 49-Month High As ‘Input Costs Show Signs Of Cooling’
- Treasury yields fall despite rate hike concerns hitting tech stocks
- Oil steady as investors focus on Hormuz flows after peace talks
- US gasoline prices tumble for sixth straight week
- US Airlines Set To Pocket $40 Billion As Jet Fuel Prices Crash
- Fed minions slow to respond to changing conditions for inflation; say Iran war oil price shock wasn’t big deal:
- Fed’s Goolsbee says labor market stable, inflation going the wrong way
- Oil shock nicked US GDP but resilience was the message, Dallas Fed research finds
- Bigger trouble, stimulus developing in China:
- China targets US rare earth and other firms with export controls
- China announces measures to expand automotive after-market
- ECB minions say they’ll wait for data, but signal more interest rate hikes are coming even as bigger trouble develops in Eurozone:
- ECB’s Kazimir: next steps will depend on data but direction is clear
- Euro zone inflation could stay high even with peace deal, ECB’s Lane says
- Euro zone private sector contraction eases in June but services stay weak, PMI shows
- U.S. stocks end deep in the red as tech trade struggles
- Wednesday, 24 June 2026
-
- Signs and portents for the U.S. economy:
- US new single-family home sales post second straight monthly decline
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- US manufacturing rises on front-loading of orders, but factory employment tumbles to six-year low
- Fed minions give passing stress test results to U.S. banks:
- Growth signs developing in China:
- BOJ minions thinking about next move to hike Japan’s interest rates:
- U.S. stocks pull back as tech selloff persists, oil prices drop
- Thursday, 25 June 2026
-
- Signs and portents for the U.S. economy:
- 10-year Treasury yield declines after May inflation data comes in as expected
- Core inflation rate hit 3.4% in May, highest since October 2023, Fed’s preferred gauge shows
- Apple stock drops 5% on MacBook and iPad price hikes due to memory crunch
- US first-quarter GDP revised sharply higher; but consumer spending nearly stalls
- US prices for new drugs fell in 2025 as fewer costly gene therapies were launched
- Oil prices at pre-war levels on rising Middle East supply
- Fed minions expected to take summer off from more rate hikes, say their policy is ‘well positioned’ to lower inflation:
- Fed expected to hold rates steady in July, hike in September
- Fed’s Williams: Inflation still too high, rate policy ‘well positioned’ to lower price pressures
- Fed’s Goolsbee sees glimmer of hope in latest inflation data
- Bigger stimulus, trouble developing in China:
- China central bank to add tool to better manage short-term liquidity
- China’s ‘future industries’ push triggers flood of venture capital, bubble concerns
- China’s carmakers rush to Canada as a ‘practice run’ for US sales
- China’s top auditor says major state banks have committed tax evasion or lending violations
- Bigger stimulus, rate hikes developing in Japan:
- Japan’s government blueprint nudges BOJ to fuel demand, clouding rates path
- Hawkish BOJ policymaker calls for rate hike once every few months
- ECB minions say persistent inflation in Eurozone will make them keep hiking interest rates:
- Wall St ends mixed as tech megacap declines outweigh upbeat chip outlook
- Friday, 26 June 2026
-
- Signs and portents for the U.S. economy:
- Oil prices dive as more tankers move through Strait of Hormuz
- Fertiliser shipments begin exiting through Hormuz strait
- Surge in imports drives US goods trade deficit to 14-month high in May
- Bigger stimulus developing in China:
- BOJ minions find inflation to fight in Japan:
- Bigger trouble developing in Eurozone:
- Tech rout drags S&P 500 to weekly decline
- Nasdaq suffers more than 4% weekly loss as Big Tech drags
The Atlanta Fed’s GDPNow tool‘s estimate of real GDP growth for the U.S. economy in the current quarter of 2026-Q2 dropped to +2.5% from the previous week’s real growth estimate of +3.0%.
Image credit: Microsoft Copilot Designer. Prompt: “An editorial cartoon of a Wall Street bull looking under the hood of a convertible while a bear points to overinflated tires labeled ‘AI’”.
Source: https://politicalcalculations.blogspot.com/2026/06/s-500-declines-as-overinflated-ai.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.



